Phase I-II Clinical Trial of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Therapy in Aggressive Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

Abstract
No abstract available
Funding Information
  • Sanofi

This publication has 31 references indexed in Scilit: